The evolving landscape of diabetes management is witnessing a exciting shift, driven by innovative incretin-based therapies. Presently, semaglutide has gained considerable recognition, but emerging medications like https://oisikhpc627701.mpeblog.com/74617699/the-future-of-diabetes-comparing-tirzepatide-semaglutide-retatrutide-and-cagrilintide